Biogen (BIIB) weekly IV elevated into EPS and new product timeline outlook

Biogen (NASDAQ: BIIB) April weekly call option implied volatility is at 112, May is at 62; compared to its 52-week range of 25 to 63 into the expected release of quarter results before the bell on April 22.

You May Also Be Interested In

• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%
• Qualcomm (QCOM) June 26 weekly 200 and 230 calls active into investor meeting